First case of type E wound botulism diagnosed using real-time PCR

Area of Science:

• Microbiology
• Infectious Diseases
• Molecular Diagnostics

Background:

• Wound botulism is an emerging public health concern, particularly within the injecting drug user population.
• Current diagnostic methods for wound botulism have limited laboratory confirmation rates, often below 50%.
• Accurate and rapid diagnosis is crucial for effective treatment and management of this severe condition.

Observation:

• A novel real-time PCR (polymerase chain reaction) assay was developed for the specific detection of Clostridium botulinum.
• The assay incorporates an internal amplification control for enhanced reliability.
• This molecular diagnostic tool targets the genes responsible for neurotoxin types A, B, and E.

Findings:

• The real-time PCR method demonstrated successful detection of Clostridium botulinum.
• The assay was utilized to identify the first documented case of wound botulism in an injecting drug user in Sweden.
• This case represents the first reported instance of wound botulism attributed to Clostridium botulinum type E.

Implications:

• The developed PCR assay offers a significant advancement in the timely and accurate diagnosis of wound botulism.
• This diagnostic tool can improve clinical management and epidemiological surveillance of wound botulism, especially in vulnerable populations.
• The identification of a Clostridium botulinum type E case highlights the need for broader diagnostic capabilities and awareness.